Suchergebnisse - "Caldwell, Michael"

PubPharm (8)

1

A pharmacogenetic versus a clinical algorithm for warfarin dosing

enthalten in: The New England journal of medicine | 2013

von Kimmel, S. | French, B. | Kasner, S. | +129

CommentIn: N Engl J Med. 2013 Dec 12;369(24):2345-6. - PMID 24251364

2

Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy

enthalten in: Thrombosis and haemostasis | 2012

von Horne, B. | Lenzini, P. | Wadelius, M. | +26

3

A randomized controlled trial of genotype-based Coumadin initiation

enthalten in: Genetics in medicine : official journal of the American College of Medical Genetics | 2011

von Burmester, J. | Berg, R. | Yale, S. | +4

CommentIn: Genet Med. 2011 Jun;13(6):505-8. - PMID 21555943

4

Understanding the pharmacogenetic approach to warfarin dosing

enthalten in: Heart failure reviews | 2010

von Glurich, I. | Burmester, J. | Caldwell, M.

5

Evaluation of genetic factors for warfarin dose prediction

enthalten in: Clinical medicine & research | 2007

von Caldwell, M. | Berg, R. | Zhang, K. | +5

ErratumIn: Clin Med Res. 2007 Jun;5(2):142

6

Impact of age, CYP2C9 genotype and concomitant medication on the rate of rise for prothrombin time during the first 30 days of warfarin therapy

enthalten in: Clinical medicine & research | 2005

von Wilke, R. | Berg, R. | Vidaillet, H. | +3

CommentIn: Clin Med Res. 2005 Nov;3(4):205-6. - PMID 16303884

7

A prospective, randomized pilot trial of model-based warfarin dose initiation using CYP2C9 genotype and clinical data

enthalten in: Clinical medicine & research | 2005

von Hillman, M. | Wilke, R. | Yale, S. | +6

8

Relative impact of covariates in prescribing warfarin according to CYP2C9 genotype

enthalten in: Pharmacogenetics | 2004

von Hillman, M. | Wilke, R. | Caldwell, M. | +3

1
[1]